Zimbabwe has turned down a substantial US healthcare agreement valued at $367m (£272m) over five years due to the United States' insistence on confidential biological samples.
This rejection came to light following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesperson later clarified that the United States was requesting health data for scientific study and commercial purposes while was not willing to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued talks to secure a agreement suitable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
According to statements, 16 African countries have to date agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our citizens should a future health crisis arise."
Sovereignty and International Frameworks
He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting frameworks already set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation might be arranged in a manner that respects the independence and interests of each country."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but urged that talks must proceed given that a large portion of the nation's HIV programmes relied on external financing.
"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group added.
The situation highlights the ongoing challenges between accepting vital international aid and safeguarding local interests in an increasingly interconnected world.